Overview

The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
0
Participant gender:
All
Summary
We will determine if linezolid inhibits cellular activation and production of pro-inflammatory cytokines, providing mechanistic rationale for its clinical efficacy and the justification for further investigations in S. Aureus sepsis.
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Utah
Collaborator:
Pfizer
Treatments:
Linezolid
Vancomycin
Criteria
Inclusion Criteria:

- Healthy, taking no medications, and not recently hospitalized

Exclusion Criteria:

- Infection (active)